OrganOx metra System

FDA Premarket Approval P200035

Pre-market Approval Supplement Details

The organox metra system is approved for the following indication: the organox metra® is a transportable device intended to be used to sustain donor livers destined for transplantation in a functioning state for a total preservation time of up to 12 hours. The organox metra® device is suitable for liver grafts from donors after brain death (dbd), or liver grafts from donors after circulatory death (dcd)

DeviceOrganOx metra System
Generic NameNormothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation
ApplicantOrganOx Limited
Date Received2020-07-15
Decision Date2021-12-09
PMAP200035
SupplementS
Product CodeQQK 
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address OrganOx Limited oxford Science Park, Magdalen Centre, Robert Robinson Avenue oxford OX4 4

Supplemental Filings

Supplement NumberDateSupplement Type
P200035Original Filing
S003 2022-06-07 Normal 180 Day Track No User Fee
S002 2022-03-21 Normal 180 Day Track No User Fee
S001 2022-03-15 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
05060462240043 P200035 002
05060462240005 P200035 002
05060462240029 P200035 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.